Hemostemix stock price went up by 1.538%
The TSX-Venture listed biotech company, Hemostemix, has experienced a hike of 6.061% on the initial value and currently lands at a $0.35 per share offer
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.